A citation-based method for searching scientific literature

Haoqiang Ying, Alec C Kimmelman, Costas A Lyssiotis, Sujun Hua, Gerald C Chu, Eliot Fletcher-Sananikone, Jason W Locasale, Jaekyoung Son, Hailei Zhang, Jonathan L Coloff, Haiyan Yan, Wei Wang, Shujuan Chen, Andrea Viale, Hongwu Zheng, Ji-hye Paik, Carol Lim, Alexander R Guimaraes, Eric S Martin, Jeffery Chang, Aram F Hezel, Samuel R Perry, Jian Hu, Boyi Gan, Yonghong Xiao, John M Asara, Ralph Weissleder, Y Alan Wang, Lynda Chin, Lewis C Cantley, Ronald A DePinho. Cell 2012
Times Cited: 1034



Jude Canon, Karen Rex, Anne Y Saiki, Christopher Mohr, Keegan Cooke, Dhanashri Bagal, Kevin Gaida, Tyler Holt, Charles G Knutson, Neelima Koppada, Brian A Lanman, Jonathan Werner, Aaron S Rapaport, Tisha San Miguel, Roberto Ortiz, Tao Osgood, Ji-Rong Sun, Xiaochun Zhu, John D McCarter, Laurie P Volak, Brett E Houk, Marwan G Fakih, Bert H O'Neil, Timothy J Price, Gerald S Falchook, Jayesh Desai, James Kuo, Ramaswamy Govindan, David S Hong, Wenjun Ouyang, Haby Henary, Tara Arvedson, Victor J Cee, J Russell Lipford. Nature 2019
Times Cited: 481




List of shared articles



Times cited

BI-3406, a Potent and Selective SOS1-KRAS Interaction Inhibitor, Is Effective in KRAS-Driven Cancers through Combined MEK Inhibition.
Marco H Hofmann, Michael Gmachl, Juergen Ramharter, Fabio Savarese, Daniel Gerlach, Joseph R Marszalek, Michael P Sanderson, Dirk Kessler, Francesca Trapani, Heribert Arnhof,[...]. Cancer Discov 2021
42

Exploiting KRAS-mediated metabolic reprogramming as a therapeutic target.
Sanne Bootsma, Sanne M van Neerven, Louis Vermeulen. Nat Genet 2021
0

KRAS mutation in pancreatic cancer.
Ji Luo. Semin Oncol 2021
2

Targeting KRAS: The Elephant in the Room of Epithelial Cancers.
Valeria Merz, Marina Gaule, Camilla Zecchetto, Alessandro Cavaliere, Simona Casalino, Camilla Pesoni, Serena Contarelli, Fabio Sabbadini, Monica Bertolini, Domenico Mangiameli,[...]. Front Oncol 2021
4

NOX4 links metabolic regulation in pancreatic cancer to endoplasmic reticulum redox vulnerability and dependence on PRDX4.
Pallavi Jain, Anna Dvorkin-Gheva, Erik Mollen, Lucie Malbeteau, Michael Xie, Fatima Jessa, Piriththiv Dhavarasa, Stephen Chung, Kevin R Brown, Gun Ho Jang,[...]. Sci Adv 2021
0

Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition.
Andrew M Waters, Tala O Khatib, Bjoern Papke, Craig M Goodwin, G Aaron Hobbs, J Nathaniel Diehl, Runying Yang, A Cole Edwards, Katherine H Walsh, Rita Sulahian,[...]. Cell Rep 2021
0

Autophagy Inhibition in BRAF-Driven Cancers.
Mona Foth, Martin McMahon. Cancers (Basel) 2021
0

Targeting KRAS in pancreatic cancer: new drugs on the horizon.
Sahar F Bannoura, Md Hafiz Uddin, Misako Nagasaka, Farzeen Fazili, Mohammed Najeeb Al-Hallak, Philip A Philip, Bassel El-Rayes, Asfar S Azmi. Cancer Metastasis Rev 2021
0

Targeting mutated GTPase KRAS in tumor therapies.
Guangjin Fan, Linlin Lou, Zhendong Song, Xiaolei Zhang, Xiao-Feng Xiong. Eur J Med Chem 2021
0

Cytotoxicity of combinations of the pan-KRAS inhibitor BAY-293 against primary non-small lung cancer cells.
Adelina Plangger, Barbara Rath, Maximilian Hochmair, Martin Funovics, Gerhard Hamilton. Transl Oncol 2021
0